Annual Accounts Payable
$1.33 M
-$1.19 M-47.21%
31 December 2023
Summary:
IGM Biosciences annual accounts payable is currently $1.33 million, with the most recent change of -$1.19 million (-47.21%) on 31 December 2023. During the last 3 years, it has fallen by -$6.60 million (-83.27%). IGMS annual accounts payable is now -83.27% below its all-time high of $7.92 million, reached on 31 December 2020.IGMS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$3.54 M
+$286.00 K+8.78%
30 September 2024
Summary:
IGM Biosciences quarterly accounts payable is currently $3.54 million, with the most recent change of +$286.00 thousand (+8.78%) on 30 September 2024. Over the past year, it has dropped by -$368.00 thousand (-9.40%). IGMS quarterly accounts payable is now -55.26% below its all-time high of $7.92 million, reached on 31 December 2020.IGMS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IGMS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.2% | -9.4% |
| 3 y3 years | -83.3% | +6.0% |
| 5 y5 years | +708.5% | +27.6% |
IGMS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.3% | at low | -36.5% | +167.3% |
| 5 y | 5 years | -83.3% | +708.5% | -55.3% | +167.3% |
| alltime | all time | -83.3% | +708.5% | -55.3% | +2061.6% |
IGM Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.54 M(+8.8%) |
| June 2024 | - | $3.26 M(-18.4%) |
| Mar 2024 | - | $4.00 M(+201.3%) |
| Dec 2023 | $1.33 M(-47.2%) | $1.33 M(-66.1%) |
| Sept 2023 | - | $3.91 M(-20.7%) |
| June 2023 | - | $4.94 M(+24.3%) |
| Mar 2023 | - | $3.97 M(+58.1%) |
| Dec 2022 | $2.51 M(-55.0%) | $2.51 M(-8.0%) |
| Sept 2022 | - | $2.73 M(-21.0%) |
| June 2022 | - | $3.46 M(-13.8%) |
| Mar 2022 | - | $4.01 M(-28.2%) |
| Dec 2021 | $5.58 M | $5.58 M(+66.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $3.35 M(-31.1%) |
| June 2021 | - | $4.85 M(-14.3%) |
| Mar 2021 | - | $5.66 M(-28.6%) |
| Dec 2020 | $7.92 M(+156.7%) | $7.92 M(+148.5%) |
| Sept 2020 | - | $3.19 M(-25.2%) |
| June 2020 | - | $4.26 M(+114.9%) |
| Mar 2020 | - | $1.98 M(-35.7%) |
| Dec 2019 | $3.09 M(+1782.3%) | $3.09 M(+11.1%) |
| Sept 2019 | - | $2.78 M(+30.2%) |
| June 2019 | - | $2.13 M(+1201.2%) |
| Dec 2018 | $164.00 K(-27.1%) | $164.00 K |
| Dec 2017 | $225.00 K | - |
FAQ
- What is IGM Biosciences annual accounts payable?
- What is the all time high annual accounts payable for IGM Biosciences?
- What is IGM Biosciences annual accounts payable year-on-year change?
- What is IGM Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for IGM Biosciences?
- What is IGM Biosciences quarterly accounts payable year-on-year change?
What is IGM Biosciences annual accounts payable?
The current annual accounts payable of IGMS is $1.33 M
What is the all time high annual accounts payable for IGM Biosciences?
IGM Biosciences all-time high annual accounts payable is $7.92 M
What is IGM Biosciences annual accounts payable year-on-year change?
Over the past year, IGMS annual accounts payable has changed by -$1.19 M (-47.21%)
What is IGM Biosciences quarterly accounts payable?
The current quarterly accounts payable of IGMS is $3.54 M
What is the all time high quarterly accounts payable for IGM Biosciences?
IGM Biosciences all-time high quarterly accounts payable is $7.92 M
What is IGM Biosciences quarterly accounts payable year-on-year change?
Over the past year, IGMS quarterly accounts payable has changed by -$368.00 K (-9.40%)